Literature DB >> 7345156

Transsexualism or the gender dysphoria syndromes.

S B Levine, L Lothstein.   

Abstract

Professional, patient and media forces tend to oversimplify the complexity of the gender dysphoria syndrome. Because sex reassignment surgery may be helpful to some patients with the syndrome and harmful to others, mental health professionals need to competently perform differential diagnoses of both the gender disorder and the associated psychopathologies. This frequently involves distinctions between subtle forms of psychosis, character pathologies of varying severity, and major developmental problems. Surgery should not be considered the only, or the best, treatment for the syndrome. Contrary to popular belief, psychotherapy can help many patients, especially those with secondary gender dysphoria.

Entities:  

Mesh:

Year:  1981        PMID: 7345156     DOI: 10.1080/00926238108406096

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  6 in total

Review 1.  Sex reassignment technology: the dilemma of transsexuals in Islam and Christianity.

Authors:  Mohd Shuhaimi Bin Haji Ishak; Sayed Sikandar Shah Haneef
Journal:  J Relig Health       Date:  2014-04

2.  Transsexuals in the military: flight into hypermasculinity.

Authors:  G R Brown
Journal:  Arch Sex Behav       Date:  1988-12

Review 3.  The classification and labeling of nonhomosexual gender dysphorias.

Authors:  R Blanchard
Journal:  Arch Sex Behav       Date:  1989-08

4.  Cross-gender identity in transvestites and male transsexuals.

Authors:  C D Doorn; J Poortinga; A M Verschoor
Journal:  Arch Sex Behav       Date:  1994-04

5.  Long-term follow-up of "sex change" in 13 male-to-female transsexuals.

Authors:  G Lindemalm; D Körlin; N Uddenberg
Journal:  Arch Sex Behav       Date:  1986-06

6.  Transgender transitioning and change of self-reported sexual orientation.

Authors:  Matthias K Auer; Johannes Fuss; Nina Höhne; Günter K Stalla; Caroline Sievers
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.